JPWO2022047249A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022047249A5 JPWO2022047249A5 JP2023513670A JP2023513670A JPWO2022047249A5 JP WO2022047249 A5 JPWO2022047249 A5 JP WO2022047249A5 JP 2023513670 A JP2023513670 A JP 2023513670A JP 2023513670 A JP2023513670 A JP 2023513670A JP WO2022047249 A5 JPWO2022047249 A5 JP WO2022047249A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- administration
- hydroxypropyl
- cyclodextrin
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 16
- 230000009885 systemic effect Effects 0.000 claims 12
- 201000001320 Atherosclerosis Diseases 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 235000012000 cholesterol Nutrition 0.000 claims 7
- 206010003210 Arteriosclerosis Diseases 0.000 claims 5
- FYHRJWMENCALJY-YSQMORBQSA-N (25R)-cholest-5-ene-3beta,26-diol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCC[C@H](CO)C)[C@@]1(C)CC2 FYHRJWMENCALJY-YSQMORBQSA-N 0.000 claims 4
- DKISDYAXCJJSLZ-UHFFFAOYSA-N 26-Hydroxy-cholesterin Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(CO)C)C1(C)CC2 DKISDYAXCJJSLZ-UHFFFAOYSA-N 0.000 claims 4
- 101150092476 ABCA1 gene Proteins 0.000 claims 4
- 108700005241 ATP Binding Cassette Transporter 1 Proteins 0.000 claims 4
- 102100022594 ATP-binding cassette sub-family G member 1 Human genes 0.000 claims 4
- 108010090314 Member 1 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 claims 4
- 102100033616 Phospholipid-transporting ATPase ABCA1 Human genes 0.000 claims 4
- 238000001990 intravenous administration Methods 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000013078 crystal Substances 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- 208000005764 Peripheral Arterial Disease Diseases 0.000 claims 2
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 2
- 208000018262 Peripheral vascular disease Diseases 0.000 claims 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims 2
- 208000029078 coronary artery disease Diseases 0.000 claims 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 2
- 238000001802 infusion Methods 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- IOWMKBFJCNLRTC-XWXSNNQWSA-N (24S)-24-hydroxycholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](O)C(C)C)[C@@]1(C)CC2 IOWMKBFJCNLRTC-XWXSNNQWSA-N 0.000 claims 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims 1
- 206010011891 Deafness neurosensory Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 208000009966 Sensorineural Hearing Loss Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 230000036765 blood level Effects 0.000 claims 1
- 229940109239 creatinine Drugs 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 231100000879 sensorineural hearing loss Toxicity 0.000 claims 1
- 208000023573 sensorineural hearing loss disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063071257P | 2020-08-27 | 2020-08-27 | |
| US63/071,257 | 2020-08-27 | ||
| PCT/US2021/048084 WO2022047249A1 (en) | 2020-08-27 | 2021-08-27 | Methods for the treatment of cardiovascular disease with cyclodextrins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023543131A JP2023543131A (ja) | 2023-10-13 |
| JPWO2022047249A5 true JPWO2022047249A5 (https=) | 2024-08-13 |
| JP2023543131A5 JP2023543131A5 (https=) | 2024-08-13 |
Family
ID=80353287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513670A Pending JP2023543131A (ja) | 2020-08-27 | 2021-08-27 | シクロデキストリンによる心血管疾患の治療方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20240000826A1 (https=) |
| EP (1) | EP4203974A4 (https=) |
| JP (1) | JP2023543131A (https=) |
| KR (1) | KR20230104119A (https=) |
| CN (1) | CN116322644A (https=) |
| AU (1) | AU2021331487A1 (https=) |
| CA (1) | CA3189915A1 (https=) |
| CO (1) | CO2023003656A2 (https=) |
| CR (1) | CR20230135A (https=) |
| IL (1) | IL300805A (https=) |
| JO (1) | JOP20230043A1 (https=) |
| MX (1) | MX2023002418A (https=) |
| PE (1) | PE20231169A1 (https=) |
| WO (1) | WO2022047249A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877778A (en) * | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| CN104244956B (zh) * | 2012-04-13 | 2020-04-17 | L&F研究有限公司 | 使用环糊精的方法 |
-
2021
- 2021-08-27 CA CA3189915A patent/CA3189915A1/en active Pending
- 2021-08-27 CN CN202180053234.0A patent/CN116322644A/zh active Pending
- 2021-08-27 AU AU2021331487A patent/AU2021331487A1/en not_active Abandoned
- 2021-08-27 EP EP21862882.4A patent/EP4203974A4/en active Pending
- 2021-08-27 MX MX2023002418A patent/MX2023002418A/es unknown
- 2021-08-27 CR CR20230135A patent/CR20230135A/es unknown
- 2021-08-27 WO PCT/US2021/048084 patent/WO2022047249A1/en not_active Ceased
- 2021-08-27 PE PE2023000716A patent/PE20231169A1/es unknown
- 2021-08-27 IL IL300805A patent/IL300805A/en unknown
- 2021-08-27 JP JP2023513670A patent/JP2023543131A/ja active Pending
- 2021-08-27 KR KR1020237010388A patent/KR20230104119A/ko not_active Withdrawn
- 2021-08-27 US US18/023,325 patent/US20240000826A1/en active Pending
-
2022
- 2022-11-11 US US17/985,762 patent/US20230091966A1/en not_active Abandoned
-
2023
- 2023-02-27 JO JOJO/P/2023/0043A patent/JOP20230043A1/ar unknown
- 2023-03-23 CO CONC2023/0003656A patent/CO2023003656A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gülberg et al. | Long‐term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine | |
| US5849740A (en) | Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes | |
| JP2020521755A5 (https=) | ||
| JP2014185161A (ja) | シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤 | |
| Pasternak et al. | Enhanced rate of progression of coronary artery disease following aortocoronary saphenous vein bypass surgery | |
| KR102008826B1 (ko) | 나토키나제와 항염증제를 유효성분으로 포함하는 혈소판 응집 억제용 또는 혈전용해용 의약 조성물 | |
| JPWO2022047249A5 (https=) | ||
| EP1190714A2 (en) | Method for the treatment of thromboembolic disorders in patients with aspirin resistance | |
| Jacob | Pulse steroids in hematologic diseases | |
| US20070155828A1 (en) | Coumarin analog compounds for safer anticoagulant treatment | |
| JPS6150927B2 (https=) | ||
| Porter et al. | Iron chelation | |
| CN104000814B (zh) | 一种防治痛风性关节炎的药物组合物及其用途 | |
| AU2002220960A1 (en) | Regeneration of blood vessels | |
| KR100895031B1 (ko) | 지질 농후 플라크의 감소, 안정화 및 파열 방지 방법 | |
| JPWO2022047241A5 (https=) | ||
| JP2020045332A (ja) | 慢性便秘症を治療するための医薬組成物 | |
| WO1999030698A1 (en) | A drug for treating diabetic nephrosis and delaying renal failure | |
| Ragoonanan et al. | Clinical update on vasopressors and titration strategies | |
| AU2008201290B2 (en) | Therapeutic treatment | |
| JP2000511550A (ja) | リポタンパク質(a)の血漿水準を低下させるための薬剤の製造のための、ラロキシフェン及び類縁化合物の使用 | |
| JP2532918B2 (ja) | グアニジノ安息香酸誘導体を有効成分として含有する抗動脈硬化剤 | |
| CN118715017A (zh) | 用2-羟基丙基-β-环糊精治疗高甘油三酯血症 | |
| CN1019545B (zh) | 制备用于治疗心律不齐的含有喹啉衍生物的组合物的方法 | |
| JPWO2023156970A5 (https=) |